Search Tufts Medicine

Displaying 1 - 16 of 16
Patient Stories
February 1, 2024
John Previti was in pre-op on the day of his kidney transplant when he mentioned that he hoped his sister Denise D’Amelio would soon have a donor as well. Minutes later, in a twist that surprised everyone, John learned his sister was at the Medical Center to receive her kidney transplant that very day.
Patient Stories
April 13, 2021
After hearing a news story about a young person who donated a kidney to someone in need, the idea of organ donation started swirling around in Jake’s head. Almost 10 years later, that idea turned into reality.
Patient Stories
June 22, 2019
After learning of a chronic kidney disease, Colleen turned to the team at Tufts MC to find a kidney donor and found a match in her teammate and now life partner.
Patient Stories
February 2, 2019
There was only one thing that was more important to Bob than receiving a kidney transplant. Seeing his son graduate. Tufts Medical Center's Kidney Transplant team made both happen.
Announcements
June 27, 2019
Meeting with heart transplant recipient at Tufts MC brings comfort, closure for donor family.
Articles
October 23, 2023
There are hundreds of thousands of people in the U.S. on organ transplant wait lists. Read Tufts Medical Center's perspective on what you can do to help.
Patient Stories
April 21, 2021
Jose was tested for COVID-19 after a few of his coworkers came down with the virus. At first, he felt fine, but then he had trouble breathing and was taken to the hospital. Soon he was in a coma and on a ventilator.
Patient Stories
April 21, 2021
Ruby was diagnosed with late-stage neuroblastoma, a type of cancer found in the small glands on top of the kidneys, when she was three. She is now 7 and playing on her swing set.
Patient Stories
April 6, 2019
Albert Plummer received the first heart transplant at Tufts Medical Center (Tufts MC), giving him 11 more years with his family doing the things he loved. He left a lasting legacy on the Tufts Medical Center CardioVascular Center.
clinical trial
...

A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 18 Years and Older With APOL1-mediated Proteinuric Kidney Disease
clinical trial
...

This is a study of the prevalence of APOL1 alleles in adults who are of recent African ancestry or geographic origin. The study will enroll up to a total of approximately 2500 subjects into 2 groups. Group 1 includes subjects with FSGS, and Group 2 includes subjects with other forms of proteinuric nondiabetic CKD. No study drug will be administered.
clinical trial
...

The purpose of this Phase II trial is to see if R3R01 is safe in patients with Alport Syndrome and Focal Segmental Glomerulosclerosis. This will be done by evaluating how efficient R3R01 is in decreasing proteinuria levels. 

The study will consist of a screening period, a treatment period, and a follow-up period. If you qualify, you will receive the study drug R3R01 for 12 weeks. We will then follow up with you after for an additional 12 weeks.
clinical trial
...

This is a phase 2, randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of atrasentan vs placebo while on background therapy with SGLT2i in subjects with IgAN. The primary efficacy assessment is the change from baseline in proteinuria (UPCR) at week 12. Eligible subjects who are enrolled in the study will be randomly assigned in a 1 to 1 ratio to either sequence AB or sequence BA.